000 01795 a2200529 4500
005 20250516190555.0
264 0 _c20140902
008 201409s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/1471-2407-14-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHasan, Raghibul
245 0 0 _aMitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis.
_h[electronic resource]
260 _bBMC cancer
_cJan 2014
300 _a2 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aCarcinoma, Squamous Cell
_xenzymology
650 0 4 _aCase-Control Studies
650 0 4 _aChi-Square Distribution
650 0 4 _aDisease-Free Survival
650 0 4 _aEsophageal Neoplasms
_xenzymology
650 0 4 _aEsophageal Squamous Cell Carcinoma
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aLymphatic Metastasis
650 0 4 _aMAP Kinase Kinase Kinase 3
_xanalysis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultivariate Analysis
650 0 4 _aOdds Ratio
650 0 4 _aProportional Hazards Models
650 0 4 _aRisk Factors
650 0 4 _aTime Factors
650 0 4 _aUp-Regulation
700 1 _aSharma, Rinu
700 1 _aSaraya, Anoop
700 1 _aChattopadhyay, Tushar K
700 1 _aDattaGupta, Siddartha
700 1 _aWalfish, Paul G
700 1 _aChauhan, Shyam S
700 1 _aRalhan, Ranju
773 0 _tBMC cancer
_gvol. 14
_gp. 2
856 4 0 _uhttps://doi.org/10.1186/1471-2407-14-2
_zAvailable from publisher's website
999 _c23410343
_d23410343